Suppr超能文献

G蛋白偶联受体中跨膜螺旋I和VII相对取向的突变分析。

Mutational analysis of the relative orientation of transmembrane helices I and VII in G protein-coupled receptors.

作者信息

Liu J, Schöneberg T, van Rhee M, Wess J

机构信息

Laboratory of Bioorganic Chemistry, NIDDK, National Institutes of Health, Bethesda, Maryland 20892, USA.

出版信息

J Biol Chem. 1995 Aug 18;270(33):19532-9. doi: 10.1074/jbc.270.33.19532.

Abstract

Currently, detailed structural information about the arrangement of the seven transmembrane helice (TM I-VII) present in all G protein-coupled receptors is still lacking. We demonstrated previously that hybrid m2/m5 muscarinic acetylcholine receptors which contain m5 sequence in TM I and m2 sequence in TM VII were unable to bind significant amounts of muscarinic radioligands (Pittel, Z., and Wess, J. (1994) Mol. Pharmacol. 45, 61-64). By using immunocytochemical and enzyme-linked immunosorbent assay techniques, we show in the present study that these pharmacologically inactive mutant receptors are present (at high levels) on the surface of transfected COS-7 cells. Strikingly, all misfolded m2/m5 hybrid receptors could be pharmacologically rescued by introduction of a single point mutation into either TM I (m5Thr37--> m2Ala30) or TM VII (m2Thr423--> m5His478). All our experimental data are consistent with the notion that the two altered threonine residues face each other at the TM 1/TM VII interface in the pharmacologically inactive m2/m5 hybrid receptors, thus interfering with proper helix-helix packing. Our data provide the first experimental evidence as to how TM I and TM VII are oriented relative to each other and also strongly suggest that the TM helices in G protein-coupled receptors are arranged in a counterclockwise fashion (as viewed from the extracellular membrane surface).

摘要

目前,关于所有G蛋白偶联受体中存在的七个跨膜螺旋(TM I-VII)排列的详细结构信息仍然缺乏。我们先前证明,在TM I中包含m5序列且在TM VII中包含m2序列的杂合m2/m5毒蕈碱型乙酰胆碱受体无法结合大量的毒蕈碱型放射性配体(Pittel,Z.和Wess,J.(1994年)《分子药理学》45卷,61-64页)。通过使用免疫细胞化学和酶联免疫吸附测定技术,我们在本研究中表明,这些药理学上无活性的突变受体(高水平地)存在于转染的COS-7细胞表面。令人惊讶的是,通过在TM I(m5Thr37→m2Ala30)或TM VII(m2Thr423→m5His478)中引入单点突变,所有错误折叠的m2/m5杂合受体都可以在药理学上得到挽救。我们所有的实验数据都与这样的观点一致,即在药理学上无活性的m2/m5杂合受体中,两个改变的苏氨酸残基在TM 1/TM VII界面处相互面对,从而干扰了螺旋-螺旋的正确堆积。我们的数据提供了关于TM I和TM VII如何相对彼此定向的首个实验证据,并且还强烈表明G蛋白偶联受体中的TM螺旋以逆时针方式排列(从细胞外膜表面观察)。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验